These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Jadidi-Niaragh F, Mirshafiey A. Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381 [Abstract] [Full Text] [Related]
5. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N, Duquette P, Prat A. Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097 [Abstract] [Full Text] [Related]
6. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway. Herold M, Posevitz V, Chudyka D, Hucke S, Groß C, Kurth F, Leder C, Loser K, Kurts C, Knolle P, Klotz L, Wiendl H. J Immunol; 2015 Oct 15; 195(8):3584-95. PubMed ID: 26378076 [Abstract] [Full Text] [Related]
8. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis. Korn T, Mitsdoerffer M, Kuchroo VK. Results Probl Cell Differ; 2010 Oct 15; 51():43-74. PubMed ID: 19513635 [Abstract] [Full Text] [Related]
9. Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis. Zhang HL, Zheng XY, Zhu J. Cytokine Growth Factor Rev; 2013 Oct 15; 24(5):443-53. PubMed ID: 23791985 [Abstract] [Full Text] [Related]
10. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity. Aggelakopoulou M, Kourepini E, Paschalidis N, Panoutsakopoulou V. J Immunol; 2016 Jun 15; 196(12):4947-56. PubMed ID: 27183630 [Abstract] [Full Text] [Related]
12. T-cells in multiple sclerosis. Severson C, Hafler DA. Results Probl Cell Differ; 2010 Jun 15; 51():75-98. PubMed ID: 19582415 [Abstract] [Full Text] [Related]
13. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Pierson E, Simmons SB, Castelli L, Goverman JM. Immunol Rev; 2012 Jul 15; 248(1):205-15. PubMed ID: 22725963 [Abstract] [Full Text] [Related]
14. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting. Stinissen P, Raus J. Acta Neurol Belg; 1999 Mar 15; 99(1):65-9. PubMed ID: 10218096 [Abstract] [Full Text] [Related]
15. Identification of a second mimicry epitope from Acanthamoeba castellanii that induces CNS autoimmunity by generating cross-reactive T cells for MBP 89-101 in SJL mice. Massilamany C, Asojo OA, Gangaplara A, Steffen D, Reddy J. Int Immunol; 2011 Dec 15; 23(12):729-39. PubMed ID: 22058327 [Abstract] [Full Text] [Related]
18. Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4. Glatigny S, Duhen R, Arbelaez C, Kumari S, Bettelli E. Sci Rep; 2015 Jan 16; 5():7834. PubMed ID: 25592296 [Abstract] [Full Text] [Related]
20. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3. Zhu E, Wang X, Zheng B, Wang Q, Hao J, Chen S, Zhao Q, Zhao L, Wu Z, Yin Z. J Immunol; 2014 Jun 15; 192(12):5599-609. PubMed ID: 24842756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]